Novartis Bioventures Ltd 13D and 13G filings for Forma Therapeutics Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-11 4:31 pm Sale |
2021-12-31 | 13G | Forma Therapeutics Holdings, Inc. FMTX |
Novartis Bioventures Ltd | 1,757,057 3.710% |
-1,234,648 (-41.27%) |
Filing |
| 2021-02-01 4:09 pm Purchase |
2020-12-31 | 13G | Forma Therapeutics Holdings, Inc. FMTX |
Novartis Bioventures Ltd | 2,991,705 6.690% |
2,991,705 (New Position) |
Filing |